Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors

PURPOSE: We evaluated whether patients with human epidermal growth factor receptor 2 (HER2) –positive primary breast tumors had metastatic tumors that were HER2 positive (concordant) or HER2 negative (discordant). We then evaluated whether treatment with trastuzumab or chemotherapy before biopsy of...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Niikura, Naoki, Liu, Jun, Hayashi, Naoki, Mittendorf, Elizabeth A., Gong, Yun, Palla, Shana L., Tokuda, Yutaka, Gonzalez-Angulo, Ana M., Hortobagyi, Gabriel N., Ueno, Naoto T.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Clinical Oncology 2012
Aiheet:
Original Reports
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3295557/
https://ncbi.nlm.nih.gov/pubmed/22124109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.33.8889
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia